bupropion hydrochloride sr

Generic: bupropion hydrochloride

Labeler: pd-rx pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupropion hydrochloride sr
Generic Name bupropion hydrochloride
Labeler pd-rx pharmaceuticals, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer
PD-Rx Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 43063-744
Product ID 43063-744_414b455c-af7f-0fa9-e063-6294a90ac1af
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206674
Listing Expiration 2026-12-31
Marketing Start 2016-07-25

Pharmacologic Class

Classes
aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43063744
Hyphenated Format 43063-744

Supplemental Identifiers

RxCUI
993518
UPC
0343063744307
UNII
ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride sr (source: ndc)
Generic Name bupropion hydrochloride (source: ndc)
Application Number ANDA206674 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-744-30)
source: ndc

Packages (1)

43063-744-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-744-30)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

BUPROPION HYDROCHLORIDE SR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "414b455c-af7f-0fa9-e063-6294a90ac1af", "openfda": {"upc": ["0343063744307"], "unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["f5d774dd-0f51-4a4f-a9d1-8b5f2364b1f7"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-744-30)", "package_ndc": "43063-744-30", "marketing_start_date": "20170209"}], "brand_name": "BUPROPION HYDROCHLORIDE SR", "product_id": "43063-744_414b455c-af7f-0fa9-e063-6294a90ac1af", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "43063-744", "generic_name": "Bupropion Hydrochloride", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA206674", "marketing_category": "ANDA", "marketing_start_date": "20160725", "listing_expiration_date": "20261231"}